INTEGRA LIFESCIENCES HOLDINGS CORP Proceeds from Divestiture of Businesses
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Proceeds from Divestiture of Businesses of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-25.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromDivestitureOfBusinesses · last filed 2025-02-25
- INTEGRA LIFESCIENCES HOLDINGS CORP proceeds from divestiture of businesses for the quarter ending 2023-12-31 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP proceeds from divestiture of businesses for the quarter ending 2022-12-31 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP proceeds from divestiture of businesses for the quarter ending 2022-09-30 was $23.96M.
- INTEGRA LIFESCIENCES HOLDINGS CORP proceeds from divestiture of businesses for the quarter ending 2022-06-30 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP proceeds from divestiture of businesses for fiscal 2024 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP proceeds from divestiture of businesses for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- INTEGRA LIFESCIENCES HOLDINGS CORP proceeds from divestiture of businesses for fiscal 2022 was $23.96M, a 87.42% decline from fiscal 2021.
- INTEGRA LIFESCIENCES HOLDINGS CORP proceeds from divestiture of businesses for fiscal 2021 was $190.47M.
| Period end | Proceeds from Divestiture of Businesses 3 month | Proceeds from Divestiture of Businesses 6 month | Proceeds from Divestiture of Businesses 9 month | Proceeds from Divestiture of Businesses 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-25 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $0.00 10-K · filed 2025-02-25 | ||
| 2023-09-30 | $0.00 10-Q · filed 2023-10-25 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $23.96M derived: sum of 2 quarters · filed 2025-02-25 | $23.96M derived: sum of 3 quarters · filed 2025-02-25 | $23.96M 10-K · filed 2025-02-25 |
| 2022-09-30 | $23.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-25 | $23.96M derived: sum of 2 quarters · filed 2023-10-25 | $23.96M 10-Q · filed 2023-10-25 | $23.96M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $0.00 10-Q · filed 2022-07-27 | $0.00 derived: sum of 3 quarters · filed 2024-02-28 | -$1.27M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $0.00 10-Q · filed 2022-04-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | -$1.27M derived: sum of 3 quarters · filed 2024-02-28 | -$1.27M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$1.27M derived: sum of 2 quarters · filed 2024-02-28 | -$1.27M derived: sum of 3 quarters · filed 2024-02-28 | $190.47M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$1.27M derived: sum of 2 quarters · filed 2022-07-27 | $190.47M 10-Q · filed 2021-11-02 | $190.47M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $191.74M 10-Q · filed 2022-07-27 | $191.74M derived: sum of 3 quarters · filed 2023-02-22 | $191.74M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $191.74M 10-Q · filed 2022-04-27 | $191.74M derived: sum of 2 quarters · filed 2023-02-22 | $191.74M derived: sum of 3 quarters · filed 2023-02-22 | $191.74M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $0.00 derived: sum of 2 quarters · filed 2023-02-22 | $0.00 derived: sum of 3 quarters · filed 2023-02-22 | $0.00 10-K · filed 2023-02-22 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $0.00 derived: sum of 2 quarters · filed 2021-11-02 | $0.00 10-Q · filed 2021-11-02 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $0.00 10-Q · filed 2021-07-29 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-04-29 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-24 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-02-21 | |||
| 2017-12-31 | $46.39M 10-K · filed 2020-02-21 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-02-26 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |